Ausgabe 11/2011
Inhalt (25 Artikel)
Reproducibility of results on chronic pain with MC5-A Calmare® device from independent studies
Marianna Ricci, Sara Pirotti, Emanuela Scarpi, Marco Burgio, Marco Maltoni, Elisabetta Sansoni, Dino Amadori
Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists
Nathaniel Bouganim, George Dranitsaris, Eitan Amir, Mark Clemons
Identifying tumor patients' depression
Susanne Singer, Anna Brown, Jens Einenkel, Johann Hauss, Andreas Hinz, Andrea Klein, Kirsten Papsdorf, Jens-Uwe Stolzenburg, Elmar Brähler
Depressive symptoms during the first chemotherapy cycle predict mortality in patients with advanced non-small cell lung cancer
Mei-Ling Chen, Min-Chi Chen, Chih-Teng Yu
“When patients and families feel abandoned”
Daniel E. Epner, Vinod Ravi, Walter F. Baile
Family physician involvement in cancer care and lung cancer patient emotional distress and quality of life
Michèle Aubin, Lucie Vézina, René Verreault, Lise Fillion, Éveline Hudon, François Lehmann, Yvan Leduc, Rénald Bergeron, Daniel Reinharz, Diane Morin
Nutritional status of patients with locally advanced pancreatic cancer: a pilot study
Leah M. Ferrucci, Diana Bell, Jennifer Thornton, Glenda Black, Ruth McCorkle, Douglas C. Heimburger, Muhammad Wasif Saif
Coping and psychological distress among head and neck cancer patients
Hawazin W. Elani, Paul J. Allison
Symptoms, psychological distress, and supportive care needs in lung cancer patients
Yu-Chien Liao, Wei-Yu Liao, Shiow-Ching Shun, Chong-Jen Yu, Pan-Chyr Yang, Yeur-Hur Lai
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
John T. Maringwa, Chantal Quinten, Madeleine King, Jolie Ringash, David Osoba, Corneel Coens, Francesca Martinelli, Jurgen Vercauteren, Charles S. Cleeland, Henning Flechtner, Carolyn Gotay, Eva Greimel, Martin J. Taphoorn, Bryce B. Reeve, Joseph Schmucker-Von Koch, Joachim Weis, Egbert F. Smit, Jan P. van Meerbeeck, Andrew Bottomley
Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy
Young Eun Ha, Jae-Hoon Song, Won Ki Kang, Kyong Ran Peck, Doo Ryeon Chung, Cheol-In Kang, Mi-Kyong Joung, Eun-Jeong Joo, Kyung Mok Shon
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak, David B. Johnson, Bronagh P. Murphy, Kendrith M. Rowland, DeAnne A. Smith, Alan R. Berg, Philip J. Stella, Charles L. Loprinzi
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine
Shih-Hung Tsai, Ming-Shen Dai, Jyh-Cherng Yu, Ching-Liang Ho, Yeu-Chin Chen, Yi-Ying Wu, Ping-Ying Chang, Woei-Yau Kao, Tsu-Yi Chao
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)
Sibylle Loibl, Volkmar Mueller, Gunter von Minckwitz, Bettina Conrad, Claus-Henning Koehne, Stephan Kremers, Helmut Forstbauer, Mattea Linder, Valentina Nekljudova, Volker Moebus
Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase
Simone Goebel, Myrna von Harscher, H. Maximilian Mehdorn
Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study
Narhari Timilshina, Shabbir Hussain, Henriette Breunis, Shabbir M. H. Alibhai
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score
Gianmauro Numico, Marcella Occelli, Elvio G. Russi, Nicola Silvestris, Raffaella Pasero, Elena Fea, Cristina Granetto, Gianna Di Costanzo, Ida Colantonio, Milena Gasco, Ornella Garrone, Valentina Polla, Marco C. Merlano
Psychometric evaluation and feasibility of the Greek Pittsburgh Sleep Quality Index (GR-PSQI) in patients with cancer receiving chemotherapy
Grigorios C. Kotronoulas, Constantina N. Papadopoulou, Anastasia Papapetrou, Elisabeth Patiraki
A qualitative assessment of the supportive care and resource needs of patients undergoing craniotomy for benign brain tumours
Janice Wong, Daniel Mendelsohn, Joyce Nyhof-Young, Mark Bernstein
Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases
Robert Olson, Scott Tyldesley, Hannah Carolan, Maureen Parkinson, Taruna Chhanabhai, Michael McKenzie
Complementary and alternative medicine use in pediatric cancer reported during palliative phase of disease
Deborah Tomlinson, Tanya Hesser, Marie-Chantal Ethier, Lillian Sung
Cancer pain management in ambulatory care: can we link assessment and action to outcomes?
Nancy Wells, M. Rachel McDowell, Patty Hendricks, Mary S. Dietrich, Barbara Murphy
The development and impact of a new Psychosocial Oncology Program
Anita Mehta, Marc Hamel
Treatment referral before and after the introduction of the Liverpool Patients Concerns Inventory (PCI) into routine head and neck oncology outpatient clinics
Naseem Ghazali, Anastasios Kanatas, Daniel J. R. Langley, Barry Scott, Derek Lowe, Simon N. Rogers